Nostrum Laboratories, Inc.
Case Number:
2:24-bk-19611
Court:
Nature of Suit:
Firms
- Ansell Grimm
- Broege Neumann
- Brown & Connery
- Buchalter APC
- Chiesa Shahinian
- Collins Vella
- Cullen & Dykman
- Dembo Brown
- Fleischer Fleischer
- Gellert Seitz
- Greenbaum Rowe
- Greenberg Traurig
- Haynes Boone
- Hogan Lovells
- Klehr Harrison
- Kriss & Feuerstein
- Kurzman Eisenberg
- Law Firm of Russell R. Johnson III
- Lowenstein Sandler
- McManimon Scotland
- Norris McLaughlin
- Orrick Herrington
- Pashman Stein
- Porzio Bromberg
- Robinson & Cole
- Stark & Stark
- Stradley Ronon
- Togut Segal
- Warshaw Burstein
- Wilson Elser
Companies
- Ansell Ltd.
- Blue Cross Blue Shield Association
- Canon Financial Services Inc.
- Canon Inc.
- Cardinal Health Inc.
- Cencora Inc.
- Enclara Pharmacia
- Humana Inc.
- McKesson Corp.
- Nostrum Laboratories Inc.
- Raymond James Financial Inc.
- Symmetry Energy Solutions LLC
- Viatris Inc.
Government Agencies
Sectors & Industries:
-
October 07, 2024
FTX Wins Plan Approval, Diamond Sports Drops MLB Deals
FTX will start repaying customers using up to $16.5 billion in assets that the fallen cryptocurrency company has recovered since filing for bankruptcy in November 2022, after a Delaware bankruptcy judge blessed FTX's reorganization plan at a hearing Monday.
-
October 01, 2024
Nostrum Labs Hits Ch. 11 A Year After Medicaid Settlement
Nostrum Laboratories, a New Jersey drugmaker that paid millions to settle allegations that it underpaid Medicaid drug rebates for its bladder infection drug after it hiked the price more than 400%, filed for Chapter 11 protection with nearly $68.3 million in debt.
- ← Previous
- 1
- 2
- Next →